ДМИТРЕНКО, І. В. Prognostic value of early reduction of BCR/ABL1 gene expression in criteria of deep molecular response on imatynib therapy in patients with chronic myeloid leukemia. Problems of Environmental Biotechnology, [S. l.], n. 1, 2018. DOI: 10.18372/2306-6407.1.12851. Disponível em: http://jrnl.kai.edu.ua/index.php/ecobiotech/article/view/12851. Acesso em: 14 jun. 2026.